Author

P. Bunn

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1

Frequent Co-Authors

B. Barber· 1 shared B. Dome· 1 shared C. Edwards· 1 shared C. Engwerda· 1 shared C. Rivard· 1 shared D. Andrew· 1 shared D. Corvino· 1 shared D. Dora· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

B. Barber

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

STING activation promotes autologous type I interferon-dependent development of type 1 regulatory T cells during malaria

Y. Wang, F. Rivera, C. Edwards, T. Frame, J. A. Engel, L. Bukali, J. Na, S. Ng, D. Corvino, M. Montes de Oca, P. Bunn, M. Soon, D. Andrew, J. Loughland, F. Amante, , C. Engwerda

This study shows STING activation promotes Tr1 cell development during malaria by enhancing IFNB gene transcription and modulates this pathway with ruxolitinib.

bioRxiv · Sep 4, 2022Immunology

Small Cell Lung Cancer Neuroendocrine Subtypes are Associated with Different Immune Microenvironment and Checkpoint Molecule Distribution

D. Dora, C. Rivard, H. Yu, P. Bunn, K. Suda, S. Ren, S. L. Pickard, V. Laszlo, T. Harko, Z. Megyesfalvi, J. Moldvay, F. R. Hirsch, B. Dome, Z. Lohinai

This study shows that NE-low SCLC tumors have more immune cell infiltration and higher expression of IDO and PVR compared to NE-high tumors, suggesting these as potential immunotherapy targets.

bioRxiv · Feb 2, 2020Cancer Biology